Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1976 1
1994 1
2005 4
2006 2
2007 1
2011 2
2012 11
2013 20
2014 23
2015 22
2016 15
2017 15
2018 22
2019 25
2020 36
2021 31
2022 25
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30365473

232 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
Sagiv O, Ding S, Ferrarotto R, Glisson B, Altan M, Johnson F, Elamin Y, Thakar SD, Nagarajan P, Esmaeli B. Sagiv O, et al. Ophthalmic Plast Reconstr Surg. 2019 Jul/Aug;35(4):350-353. doi: 10.1097/IOP.0000000000001251. Ophthalmic Plast Reconstr Surg. 2019. PMID: 30365473
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.
Sekulic A, Migden MR, Lewis K, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Dirix L, Hou J, Yue H, Hauschild A; ERIVANCE BCC investigators. Sekulic A, et al. J Am Acad Dermatol. 2015 Jun;72(6):1021-6.e8. doi: 10.1016/j.jaad.2015.03.021. J Am Acad Dermatol. 2015. PMID: 25981002 Clinical Trial.
232 results